Status:

COMPLETED

Understanding Experimentally Induced Hot Flushes

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

Endocrine Research Society

Conditions:

Hot Flashes

Eligibility:

FEMALE

18-45 years

Phase:

PHASE4

Brief Summary

The purpose of the study is to examine the impact of hot flushes on sleep, mood, and well-being. The investigators will cause hot flushes by giving study participants the hormone medication, leuprolid...

Eligibility Criteria

Inclusion

  • Women 18-45 years old
  • Premenopausal
  • Willingness to use barrier methods of contraception during study and after completion of study until menses resume
  • Good general health

Exclusion

  • Pregnancy
  • Breastfeeding
  • Hot flushes
  • Hemoglobin at the screening visit less than 10 gm/dL
  • Abnormal liver function tests
  • Abnormal renal function tests
  • BMI \> 35 kg/m2
  • Previously diagnosed osteoporosis or osteopenia
  • Psychiatric disorder involving mood, anxiety, psychotic disorder, current anorexia nervosa, or current alcohol or substance-use disorder
  • Previous severe depression
  • Evidence of suicidal or homicidal ideation
  • Sleep apnea, narcolepsy, or other diagnosed sleep disorder
  • Contraindication, hypersensitivity, or previous allergic reaction to GnRH agonists
  • Regular use of centrally active medications
  • Use of hormonal medications for at least 2 months
  • Use of ketoconazole, clomiphene citrate, or anabolic/androgenic steroids in the preceding 3 months
  • Renal insufficiency
  • Abnormal vaginal bleeding
  • History of thrombo-embolism or cardiovascular disease
  • History of congestive heart failure or other conditions requiring sodium restriction
  • History of spinal cord compression
  • Metastatic vertebral lesions
  • Memory disorders
  • Urinary tract obstruction
  • History of liver, kidney, pulmonary, or metabolic disease

Key Trial Info

Start Date :

November 28 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 2 2007

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00455689

Start Date

November 28 2005

End Date

September 2 2007

Last Update

September 18 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114